“…During the early 1990s, Hirschmann and colleagues at the University of Pennsylvania introduced the use of β- d -glucose, its enantiomers, and a diastereomer (β- d -mannose) as scaffolds for the synthesis of ligands for the somatostatin, the substance P, and the β 2 -adrenergic receptors . Since this contribution, monosaccharides, due to their polyfunctional nature, have been a basis for generating a wide range of compounds for screening. The glucopyranoside 3 (Scheme ) prepared by the Hirschmann group, and containing the lysine, tryptophan, and phenylalanine side chains of 1 , was found to be a ligand for somatostatin receptors, indicating that truncated mimetics are of interest.…”